Amendment in Export Policy of Diagnostic kits
Show AI Summary
Export liberalisation of diagnostic kits makes previously restricted COVID-19 testing supplies freely exportable under foreign trade policy.
The notification amends the export policy to reclassify a range of COVID 19 diagnostic kits, consumables, reagents, enzymes, and related apparatus from Restricted to Free. It lists specific categories-VTM kits, RNA extraction kits, RT PCR kits, rapid antigen kits, swabs, tubes, silicon columns, carrier RNA, Proteinase K, magnetic stands, beads, probes, primers, polymerases, reverse transcriptase, and dNTPs-and states that all diagnostic kits and reagents previously restricted by earlier notifications are now freely exportable with immediate effect.